These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 2872124

  • 1. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R, Lønnes T, Møgster B, Berdal BP.
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [Abstract] [Full Text] [Related]

  • 2. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
    Chodorowska M.
    Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
    [Abstract] [Full Text] [Related]

  • 3. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
    Nagel J, de Graaf S, Schijf-Evers D.
    Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
    [Abstract] [Full Text] [Related]

  • 4. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y, Sato H.
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [Abstract] [Full Text] [Related]

  • 5. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 6. Analysis of antibody profiles in children with whooping cough.
    Novotny P, Macaulay ME, Hart TC, Skvaril F.
    Dev Biol Stand; 1991 Mar; 73():267-73. PubMed ID: 1778318
    [Abstract] [Full Text] [Related]

  • 7. Class-specific antibody response to lymphocytosis promoting factor (LPF) and fimbriae (F) in pertussis.
    Viljanen MK, Mertsola J, Kuronen T, Ruuskanen O.
    Dev Biol Stand; 1985 Mar; 61():337-40. PubMed ID: 2872122
    [Abstract] [Full Text] [Related]

  • 8. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
    Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI, APERT Study.
    J Infect Dis; 2004 Aug 01; 190(3):535-44. PubMed ID: 15243929
    [Abstract] [Full Text] [Related]

  • 9. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W, Smietańska K, Rokosz-Chudziak N, Jagielski M.
    Med Dosw Mikrobiol; 2013 Aug 01; 65(4):269-74. PubMed ID: 24730215
    [Abstract] [Full Text] [Related]

  • 10. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L.
    APMIS; 2009 Sep 01; 117(9):660-71. PubMed ID: 19703126
    [Abstract] [Full Text] [Related]

  • 11. Serological responses to infection with B. pertussis.
    Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A.
    Dev Biol Stand; 1997 Sep 01; 89():213-20. PubMed ID: 9272353
    [Abstract] [Full Text] [Related]

  • 12. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
    Zackrisson G, Taranger J, Trollfors B.
    J Pediatr; 1990 Feb 01; 116(2):190-4. PubMed ID: 2299488
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM.
    Vaccine; 2009 Nov 05; 27(47):6530-6. PubMed ID: 19729085
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB, Huang YY, Halperin SA, Anderson R, Morris A, Macmillan A, Jones T, Burt DS, Van Nest G, Lee SF.
    Clin Exp Immunol; 2006 Jun 05; 144(3):543-51. PubMed ID: 16734625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of serologic assays for diagnosis of whooping cough.
    Granström G, Wretlind B, Salenstedt CR, Granström M.
    J Clin Microbiol; 1988 Sep 05; 26(9):1818-23. PubMed ID: 2903178
    [Abstract] [Full Text] [Related]

  • 18. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I.
    Tokai J Exp Clin Med; 1988 Sep 05; 13 Suppl():15-9. PubMed ID: 2908519
    [Abstract] [Full Text] [Related]

  • 19. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D, Aslan A, Sönmez C, Koturoğlu G, Cöplü N, Kurugöl Z, Aydemir S.
    Mikrobiyol Bul; 2012 Apr 05; 46(2):211-24. PubMed ID: 22639310
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.